http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-689614-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25f5e60cca882cd756ee1cd36c3fef16 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0447 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0452 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04 |
| filingDate | 1951-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1953-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-689614-A |
| titleOfInvention | Radiopaque composition |
| abstract | An X-ray contrast media for extravenous injection comprises a water-soluble salt of 3-acetylamino-2,4,6-triiodobenzoic acid and hyaluronidase in aqueous solution. The water-soluble salts specified are the ammonium, trimethylammonium, but particularly the sodium salt. A statement of prior knowledge refers to mixtures of hyaluronidase with either disodium N-methyl-3,5-diiodochelidamate or diiodo-pyridone acetic acid diethanolamine. |
| priorityDate | 1950-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.